Want to see TSE:VM full AI Analyst Report?
Voyageur Pharmaceuticals (VM) Stock Statistics & Valuation Metrics
Total Valuation
Voyageur Pharmaceuticals has a market cap or net worth of CAD 27.16M. The enterprise value is CAD 36.28M.
- Market Cap
- CAD 27.16M
- Enterprise Value
- CAD 36.28M
Share Statistics
Voyageur Pharmaceuticals has 226,342,350 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 226,342,350
- Owned by Insiders
- 0.61%
- Owned by Institutions
- ―
Financial Efficiency
Voyageur Pharmaceuticals’s return on equity (ROE) is -2.82 and return on invested capital (ROIC) is -273.32%.
- Return on Equity (ROE)
- -2.82
- Return on Assets (ROA)
- -1.14
- Return on Invested Capital (ROIC)
- -273.32%
- Return on Capital Employed (ROCE)
- -2.73
- Revenue Per Employee
- 238.469
- Profits Per Employee
- -72.09K
- Employee Count
- 49
- Asset Turnover
- 0.00
- Inventory Turnover
- 25.11
Valuation Ratios
The current PE Ratio of Voyageur Pharmaceuticals is -7.40. Voyageur Pharmaceuticals’s PEG ratio is -0.86.
- PE Ratio
- -7.40
- PS Ratio
- 556.35
- PB Ratio
- 6.63
- Price to FCF
- -9.06
- Price to Operating Cash Flow
- -8.96
- PEG Ratio
- -0.86
Income Statement
In the last 12 months, Voyageur Pharmaceuticals had revenue of 11.69K and earned -3.53M in profits. Earnings per share was -0.02.
- Revenue
- 11.69K
- Gross Profit
- -1.22M
- Operating Income
- -3.53M
- Pretax Income
- -3.53M
- Net Income
- -3.53M
- EBITDA
- -3.53M
- Earnings Per Share (EPS)
- -0.02
Cash Flow
In the last 12 months, operating cash flow was -1.01M and capital expenditures 3, giving a free cash flow of -1.01M billion.
- Operating Cash Flow
- -1.01M
- Free Cash Flow
- -1.01M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
Voyageur Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -11.04%
- Earnings Yield
- -11.29%
Stock Price Statistics
- Beta
- 0.14
- 52-Week Price Change
- -21.88%
- 50-Day Moving Average
- 0.15
- 200-Day Moving Average
- 0.13
- Relative Strength Index (RSI)
- 45.31
- Average Volume (3m)
- 153.72K
Important Dates
Voyageur Pharmaceuticals upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 30, 2026
- Next Earnings Date
- Apr 01, 2027
- Ex-Dividend Date
- ―
Financial Position
Voyageur Pharmaceuticals as a current ratio of 0.33, with Debt / Equity ratio of 3.19%
- Current Ratio
- 0.33
- Quick Ratio
- 0.30
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.06
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Voyageur Pharmaceuticals has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Voyageur Pharmaceuticals EV to EBITDA ratio is -8.40, with an EV/FCF ratio of -8.49.
- EV to Sales
- 521.56
- EV to EBITDA
- -8.40
- EV to Free Cash Flow
- -8.49
- EV to Operating Cash Flow
- -8.49
Balance Sheet
Voyageur Pharmaceuticals has CAD 441.87K in cash and marketable securities with CAD 40.00K in debt, giving a net cash position of CAD 401.87K billion.
- Cash & Marketable Securities
- CAD 441.87K
- Total Debt
- CAD 40.00K
- Net Cash
- CAD 401.87K
- Net Cash Per Share
- CAD 0.00
- Tangible Book Value Per Share
- CAD 0.00
Margins
Gross margin is -3914.52%, with operating margin of -6214.51%, and net profit margin of -6210.22%.
- Gross Margin
- -3914.52%
- Operating Margin
- -6214.51%
- Pretax Margin
- -6210.22%
- Net Profit Margin
- -6210.22%
- EBITDA Margin
- -6211.72%
- EBIT Margin
- -6214.51%
Analyst Forecast
The average price target for Voyageur Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 360.63%
- EPS Growth Forecast
- 14.21%
Scores
- Smart Score
- ―
- AI Score
- 47
